非布司他价格多少?
How much does it cost? It is understood that the generic version of Febuxostat is currently on the market in India. The Indian version of Febuxostat is produced by Zydus Pharmaceuticals in India. Its efficacy is the same as that of the original drug, but the price is much lower. The specification is 80mg*30 tablets/box, and its price is about $200. It is currently the most cost-effective drug.
Febuxostat is a xanthine oxidase (XO) inhibitor that binds to xanthine oxidase through a non-competitive mechanism, inhibits xanthine oxidase activity, inhibits the production of uric acid, and achieves the purpose of reducing acidity. Therefore, it is suitable for the long-term treatment of hyperuricemia with gout symptoms. Not recommended for asymptomatic hyperuricemia. Febuxostat is a newly developed drug. At the same dose, febuxostat has a stronger effect in reducing blood uric acid. Therefore, when it comes to the choice of gout acid-lowering drugs, many patients prefer febuxostat.
Gout is a relatively common disease, and the disease is relatively stubborn. It is recommended that patients take medication as early as possible in the early stages of the disease. Generally speaking, in addition to the common hyperuricemia, gout will also cause gouty acute arthritis, tophi deposition, tophi chronic arthritis, joint deformities, nephritis, and uric acid kidney stones. Hyperuricemia often refers to the situation where patients have fasting blood uric acid levels that are higher than normal under a normal purine diet. Patients may be asymptomatic, or may have conditions such as arthritis, gout, and high blood pressure.
As a specialized drug for gout, Febuxostat tablets are relatively effective and safe. Febuxostat applied for marketing in Japan in early 2004. It was approved for marketing by China in 2013, benefiting more domestic gout patients.
Medical Travel is an overseas medical service organization. Medical Travel cooperates with Indian pharmaceutical companies and can directly contact pharmaceutical companies to help patients purchase genuine medicines. For more drug information, patients can consult a medical companion.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)